India’s pharmaceutical exports rebounded strongly in FY24 with a 10% rise, reaching $27.9 billion. The growth was powered by U.S. and EU demand, aided by global recognition of Indian generics and supportive government initiatives. Here's what this means for the future of Indian pharma.
India’s pharma leader Sun Pharma reported a 24% profit jump in Q4 2025, fueled by rising demand for rare disease treatments and specialty drugs. While domestic performance remains strong, global challenges and innovative breakthroughs in drug development are reshaping the pharmaceutical landscape. This article explores the company’s growth, industry trends, and what the future holds for India’s pharma sector.
